Qualitek Labs Ltd
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.[1]
- Market Cap ₹ 311 Cr.
- Current Price ₹ 312
- High / Low ₹ 375 / 215
- Stock P/E 49.4
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -19.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Consulting Services
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | |
|---|---|---|---|
| 6.35 | 12.00 | 70.23 | |
| 5.63 | 10.74 | 53.99 | |
| Operating Profit | 0.72 | 1.26 | 16.24 |
| OPM % | 11.34% | 10.50% | 23.12% |
| 0.02 | 0.05 | 0.52 | |
| Interest | 0.01 | 0.32 | 2.09 |
| Depreciation | 0.35 | 0.51 | 4.25 |
| Profit before tax | 0.38 | 0.48 | 10.42 |
| Tax % | 60.53% | 12.50% | 26.30% |
| 0.16 | 0.42 | 7.68 | |
| EPS in Rs | 160.00 | 9.13 | 6.31 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 80% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 147% |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.01 | 0.46 | |
| Reserves | -0.54 | 0.42 | |
| 11.22 | 17.35 | ||
| 3.65 | 2.80 | ||
| Total Liabilities | 14.34 | 21.03 | |
| 6.33 | 7.60 | ||
| CWIP | 4.47 | 4.47 | |
| Investments | 0.00 | 0.00 | |
| 3.54 | 8.96 | ||
| Total Assets | 14.34 | 21.03 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | |
|---|---|---|---|
| 1.35 | -5.15 | ||
| -6.06 | -1.77 | ||
| 4.82 | 6.80 | ||
| Net Cash Flow | 0.11 | -0.12 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 68.98 | 66.92 | |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 68.98 | 66.92 | |
| Working Capital Days | -70.70 | 89.42 | |
| ROCE % | 5.53% |
Documents
Announcements
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Approval Of Credit Facilities And Issuance Of Corporate Guarantee
5 Jul - Qualitek Labs approved ₹13.18 Cr corporate guarantee and credit facilities of ₹95.07 Cr from Kotak Mahindra and HDFC Banks.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On July 05, 2025, Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015
5 Jul - Board approved ₹13.18 Cr corporate guarantee and credit facilities of ₹35.07 Cr and ₹60 Cr from Kotak Mahindra and HDFC Banks.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
5 Jul - Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June 30, 2025.
-
Reg. 34 (1) Annual Report.
2 Jul - Annual report filed; Rs. 51.49 Cr preferential issue; authorized capital raised to Rs. 15 Cr; acquisitions approved; MD remuneration revised.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
26 Jun - EGM held; special resolutions for equity issuance and loans to subsidiaries approved unanimously.
Annual reports
Concalls
-
May 2025TranscriptNotesPPT
Business Profile[1] Qualitek Labs Ltd. (QLL) provides testing, inspection, homologation, certification, and consultancy services to various industries viz automotive, defense, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.